Literature DB >> 9333175

CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.

T L Hoffman1, R R MacGregor, H Burger, R Mick, R W Doms, R G Collman.   

Abstract

Persons who are homozygous for the delta32 polymorphism of the CCR5 chemokine receptor gene are highly protected against human immunodeficiency virus type 1 (HIV-1) infection. Previous studies described 54 HIV-1-discordant couples in whom no virus transmission occurred despite extensive sexual contact. The possible role of the delta32 polymorphism in the lack of HIV-1 transmission between these partners was studied. No participants were homozygous for the delta32 allele, but the proportion that was heterozygous was higher among HIV-1-seronegative than HIV-1-seropositive partners (28% vs. 11%, P = .05). This association was seen in heterosexual couples (P = .03) but not in homosexual couples (P = .74). Among white persons, who are most likely to carry the delta32 allele, 38.9% of HIV-1-uninfected and 5.6% of HIV-1-infected heterosexual partners were heterozygous (P = .04). These data are consistent with a possible association between the heterozygous delta32 genotype in heterosexual sex partners and partial protection against HIV-1 infection, and they emphasize the importance of analyzing different risk groups in studies of host factors that influence infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333175     DOI: 10.1086/516519

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection.

Authors:  Jacob T Minang; Matthew T Trivett; Eugene V Barsov; Gregory Q Del Prete; Charles M Trubey; James A Thomas; Robert J Gorelick; Michael Piatak; David E Ott; Claes Ohlen
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

2.  Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.

Authors:  Jianming Tang; Brent Shelton; Nina J Makhatadze; Yuting Zhang; Margaret Schaen; Leslie G Louie; James J Goedert; Eric C Seaberg; Joseph B Margolick; John Mellors; Richard A Kaslow
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors:  E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.

Authors:  J Rucker; A L Edinger; M Sharron; M Samson; B Lee; J F Berson; Y Yi; B Margulies; R G Collman; B J Doranz; M Parmentier; R W Doms
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.

Authors:  Florian Hladik; Huanliang Liu; Emily Speelmon; Devon Livingston-Rosanoff; Sean Wilson; Polachai Sakchalathorn; Yon Hwangbo; Benjamin Greene; Tuofu Zhu; M Juliana McElrath
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I.

Authors:  Grant R Yeaman; Susana Asin; Sally Weldon; Douglas J Demian; Jane E Collins; Jorge L Gonzalez; Charles R Wira; Michael W Fanger; Alexandra L Howell
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

7.  CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.

Authors:  Sean Philpott; Barbara Weiser; Patrick Tarwater; Sten H Vermund; Cynthia A Kleeberger; Stephen J Gange; Kathryn Anastos; Mardge Cohen; Ruth M Greenblatt; Andrea Kovacs; Howard Minkoff; Mary A Young; Paolo Miotti; Michelle Dupuis; Chih-Hsiung Chen; Harold Burger
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

8.  Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Authors:  Yi Liu; Amanda Woodward; Haiying Zhu; Thomas Andrus; John McNevin; Jean Lee; James I Mullins; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.

Authors:  Brandon L Walter; Andrew E Armitage; Stephen C Graham; Tulio de Oliveira; Peter Skinhøj; E Yvonne Jones; David I Stuart; Andrew J McMichael; Bruce Chesebro; Astrid Kn Iversen
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

10.  R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms.

Authors:  Tatsuyoshi Kawamura; Forrest O Gulden; Makoto Sugaya; David T McNamara; Debra L Borris; Michael M Lederman; Jan M Orenstein; Peter A Zimmerman; Andrew Blauvelt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.